STOCK TITAN

CRH: About 99.6% of Arcosa 2032 notes tendered early

Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

CRH plc reported early results of tender and exchange offers for Arcosa notes. The offers cover Arcosa’s 4.375% senior notes due 2029 and 6.875% senior notes due 2032. By November 18, 2026, holders tendered $366.245 million of the $400 million outstanding 2029 notes in the cash offer and $12.272 million in the exchange offer; for the $600 million outstanding 2032 notes, the respective amounts were $594.306 million and $3.118 million. Combined tender and exchange participation was approximately 94.63% for the 2029 notes and 99.57% for the 2032 notes.

CRH America Finance, Inc. may issue up to $1,000,000,000 aggregate principal amount of new notes in the exchange offers. Cash purchases for notes tendered by the early deadline are expected November 20, 2026, and exchanges are expected December 8, 2026; acceptance remains subject to offer conditions. Arcosa received sufficient consents for amendments to both indentures; supplemental indentures become operative upon CRH AF’s purchase of all notes validly tendered into the cash offers by the early settlement date. The offers expire December 4, 2026, unless extended or earlier terminated, and withdrawal rights expired November 18, subject to limited legal exceptions.

Filing Explained

If accepted, the exchange would replace Arcosa notes with new CRH America Finance notes fully and unconditionally guaranteed by CRH plc; the reported tenders are not completed exchanges.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Maximum aggregate principal amount of new notes in exchange offers Up to $1,000,000,000 New CRH America Finance notes
2029 notes tendered in cash offer $366.245 million By November 18, 2026; $400 million aggregate principal amount outstanding
2029 notes tendered for exchange $12.272 million By November 18, 2026
2029 notes tendered in total Approximately 94.63% Combined tender and exchange offers
2032 notes tendered in cash offer $594.306 million By November 18, 2026; $600 million aggregate principal amount outstanding
2032 notes tendered for exchange $3.118 million By November 18, 2026
2032 notes tendered in total Approximately 99.57% Combined tender and exchange offers
Early tender premium for cash purchase $50 per $1,000 principal amount Arcosa notes accepted for purchase
Tender Offers financial
"cash tender offers by CRH America Finance"
A tender offer is a proposal by one company or individual to buy shares from existing owners of a company at a specified price within a certain time frame. It matters to investors because it can lead to changes in company ownership or control, potentially affecting the value of their investments. Essentially, it’s a way for someone to try to purchase a large portion of a company’s stock directly from shareholders.
Exchange Offers financial
"offers to eligible holders to exchange"
An exchange offer is a proposal by a company to swap its existing financial instruments, like bonds or debt, for new ones, often with different terms or maturity dates. For investors, it provides a chance to adjust their holdings, often aiming for better returns or more favorable conditions, while helping the company manage its finances more effectively.
Proposed Amendments regulatory
"certain proposed amendments to the indentures"
supplemental indentures regulatory
"executed and delivered supplemental indentures"
Supplemental indentures are formal amendments to the original contract that governs a bond or other debt, changing terms such as repayment schedule, interest, collateral, or borrower promises. They matter to investors because they can increase or reduce the risk and value of a security—like updating a rental agreement for new rules—so investors need to know whether protections were weakened, strengthened, or left unchanged.
Early Tender Deadline financial
"as of 5:00 p.m. on November 18, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much of CRH’s Arcosa 2029 and 2032 notes was tendered?

As of November 18, 2026, $366.245 million of the 2029 notes and $594.306 million of the 2032 notes were tendered in the cash offers; another $12.272 million and $3.118 million, respectively, were tendered for exchange. Combined participation was approximately 94.63% and 99.57%, respectively.

When are CRH’s Arcosa note tender and exchange offers expected to settle?

Cash purchases are expected November 20, 2026, and exchanges are expected December 8, 2026. CRH America Finance’s obligation to accept and pay for or exchange notes is subject to satisfaction or waiver of offer conditions.

What do early participants in CRH’s Arcosa offers receive?

For Arcosa notes accepted for cash purchase, the early tender premium is $50 per $1,000 principal amount; for notes accepted for exchange, the early exchange consideration is $1,000 principal amount of new CRH America Finance notes per $1,000 principal amount of Arcosa notes. The early terms apply to notes tendered by the applicable early deadline and accepted.

When do CRH’s Arcosa note offers expire?

The offers expire at 5:00 p.m. New York City time on December 4, 2026, unless extended or earlier terminated. Withdrawal and revocation rights expired at 5:00 p.m. New York City time on November 18, 2026, except in certain limited circumstances where additional rights are required by law.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
CRH PUBLIC LTD CO false 0000849395 0000849395 2026-11-19 2026-11-19 0000849395 us-gaap:CommonStockMember 2026-11-19 2026-11-19 0000849395 crh:M5.200GuaranteedNotesDue20297Member 2026-11-19 2026-11-19 0000849395 crh:FivePointOneTwoFivePercentGuaranteedNotesDue2030Member 2026-11-19 2026-11-19 0000849395 crh:M4.400GuaranteedNotesDue20311Member 2026-11-19 2026-11-19 0000849395 crh:M5.375GuaranteedNotesDue20322Member 2026-11-19 2026-11-19 0000849395 crh:SixPointFourPercentNotesDue2033Member 2026-11-19 2026-11-19 0000849395 crh:M5.400GuaranteedNotesDue20343Member 2026-11-19 2026-11-19 0000849395 crh:M5.625GuaranteedNotesDue20344Member 2026-11-19 2026-11-19 0000849395 crh:FivePointFivePercentGuaranteedNotesDue2035Member 2026-11-19 2026-11-19 0000849395 crh:FivePercentGuaranteedNotesDue2036Member 2026-11-19 2026-11-19 0000849395 crh:M5.750GuaranteedNotesDue20375Member 2026-11-19 2026-11-19 0000849395 crh:FivePointEightSevenFivePercentGuaranteedNotesDue2055Member 2026-11-19 2026-11-19 0000849395 crh:FivePointSixPercentGuaranteedNotesDue2056Member 2026-11-19 2026-11-19 0000849395 crh:M6.250GuaranteedNotesDue20576Member 2026-11-19 2026-11-19
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 19, 2026

 

 

 

LOGO

CRH public limited company

(Exact name of registrant as specified in its charter)

 

 

 

Ireland   001-32846   98-0366809

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

Stonemason’s Way, Rathfarnham, Dublin 16, D16 KH51, Ireland

(Address of principal executive offices)

+353 1 404 1000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Ordinary Shares of €0.32 each   CRH   New York Stock Exchange
5.200% Guaranteed Notes due 2029   CRH/29   New York Stock Exchange
5.125% Guaranteed Notes due 2030   CRH/30   New York Stock Exchange
4.400% Guaranteed Notes due 2031   CRH/31   New York Stock Exchange
5.375% Guaranteed Notes due 2032   CRH/32   New York Stock Exchange
6.400% Notes due 2033   CRH/33A   New York Stock Exchange
5.400% Guaranteed Notes due 2034   CRH/34   New York Stock Exchange
5.625% Guaranteed Notes due 2034   CRH/34A   New York Stock Exchange
5.500% Guaranteed Notes due 2035   CRH/35   New York Stock Exchange
5.000% Guaranteed Notes due 2036   CRH/36   New York Stock Exchange
5.750% Guaranteed Notes due 2037   CRH/37   New York Stock Exchange
5.875% Guaranteed Notes due 2055   CRH/55   New York Stock Exchange
5.600% Guaranteed Notes due 2056   CRH/56   New York Stock Exchange
6.250% Guaranteed Notes due 2057   CRH/57   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

☐

Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

 
 


Item 8.01.

Other Events

On November 19, 2026, CRH plc issued a press release announcing the early tender results of the previously announced (i) cash tender offers by CRH America Finance, Inc. to purchase any and all of the outstanding 4.375% Senior Notes due 2029 and 6.875% Senior Notes due 2032 (the “Arcosa Notes”), issued by Arcosa, Inc. (“Arcosa”) and (ii) private offers to eligible holders to exchange any and all of the Arcosa Notes for up to $1,000,000,000 aggregate principal amount of new notes issued by CRH America Finance, Inc. and fully and unconditionally guaranteed by CRH plc. A copy of the press release announcing these results is attached hereto as Exhibit 99.1.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

No.

   Description
99.1    Press release dated November 19, 2026, issued by CRH plc 
104    Cover Page Interactive Data File (formatted in Inline XBRL).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 19, 2026

 

CRH plc
 

   /s/ Aylwyn Bryan

By:      Aylwyn Bryan
     Chief Financial Officer

Exhibit 99.1

 

LOGO   

1350 Avenue of the Americas

New York, NY 10019

 

LOGO

Press Release

CRH announces Early Results of Tender Offers, Exchange Offers and Consent Solicitations for Arcosa, Inc. Notes

 

LOGO

NEW YORK – November 19, 2026 – CRH plc (NYSE: CRH) announced today the early results of the previously announced (i) cash tender offers (the “Tender Offers” and each a “Tender Offer”) by CRH America Finance, Inc. (“CRH AF”), to purchase any and all of the outstanding 4.375% Senior Notes due 2029 (the “2029 Arcosa Notes”) and 6.875% Senior Notes due 2032 (the “2032 Arcosa Notes” and, together with the 2029 Arcosa Notes, the “Arcosa Notes”), issued by Arcosa, Inc. (“Arcosa”), an indirect wholly owned subsidiary of CRH, (ii) offers to eligible holders to exchange (the “Exchange Offers” and each an “Exchange Offer”, and together with the Tender Offers, the “Offers” and each an “Offer”) any and all of the Arcosa Notes for up to $1,000,000,000 aggregate principal amount of new notes issued by CRH AF and fully and unconditionally guaranteed by CRH plc (the “New CRH AF Notes”) and (iii) related solicitations of consent (the “Consent Solicitations” and each a “Consent Solicitation”) by Arcosa from holders of the Arcosa Notes with respect to certain proposed amendments (the “Proposed Amendments”) to the indentures governing the Arcosa Notes (the “Existing Arcosa Indentures”). The terms and conditions of the Offers and related Consent Solicitations are described in the Offer to Purchase, dated November 4, 2026 (the “Offer to Purchase”), and the Offering Memorandum, dated November 4, 2026 (the “Offering Memorandum”), as applicable, and remain unchanged.

The table below sets forth the principal amount of each series of Arcosa Notes that were validly tendered, and not validly withdrawn (and related consents thereby delivered), as of 5:00 p.m., New York City time, on November 18, 2026 (the “Early Tender Deadline” with respect to the Tender Offers, and the “Early Tender Date” with respect to the Exchange Offers). Each holder of Arcosa Notes who validly tendered Arcosa Notes in an Offer is deemed to have delivered its consent, with respect to the principal amount of such tendered Arcosa Notes, to the Proposed Amendments to the corresponding Existing Arcosa Indenture. Withdrawal and revocation rights for the Offers and related Consent Solicitations expired at 5:00 p.m., New York City time, on November 18, 2026. As a result, tenders of Arcosa Notes may not be withdrawn, and delivered consents may not be revoked, except in certain limited circumstances where additional withdrawal or revocation rights are required by law.


LOGO

 

Title of

Arcosa

Notes

  

CUSIP / ISIN

   Aggregate
Principal
Amount
Outstanding
     Principal
Amount
Tendered in

the Tender
Offer at Early
Tender

Deadline
     Approximate
Percentage

of
Outstanding
Principal
Amount
Tendered in

the Tender
Offer
    Principal
Amount
Tendered in

the
Exchange
Offer at
Early Tender
Date
     Approximate
Percentage
of
Outstanding
Principal
Amount
Tendered in

the
Exchange
Offer
    Total
Approximate
Percentage

of
Outstanding
Notes

Tendered in
the Offers
 

4.375% Senior Notes due 2029

  

039653AA8 /

US039653AA89

(Rule 144A)

U2214LAA6 /

USU2214LAA62

(Reg S)

   $ 400,000,000      $ 366,245,000        91.56 %    $ 12,272,000        3.07 %      94.63 % 

6.875% Senior Notes due 2032

  

039653AC4 /

US039653AC46

(Rule 144A)

U2214LAB4 /

USU2214LAB46

(Reg S)

   $ 600,000,000      $ 594,306,000        99.05 %    $ 3,118,000        0.52 %      99.57 % 

LOGO

Payment for Arcosa Notes validly tendered, and not validly withdrawn, into the applicable Tender Offer by the Early Tender Deadline and accepted for purchase is expected to be made on November 20, 2026 (the “Early Settlement Date”). There is no early settlement date with respect to the Exchange Offers and the exchange of Arcosa Notes validly tendered, and not validly withdrawn, in the applicable Exchange Offer by the Early Tender Date and accepted for exchange is expected to be made on December 8, 2026 (the “Final Settlement Date”). CRH AF’s obligation to accept for purchase or exchange, and to pay for or exchange, Arcosa Notes validly tendered in the Offers is subject to the satisfaction or waiver of a number of conditions described in the Offer to Purchase and the Offering Memorandum, as applicable.

CRH also announced that, as of November 18, 2026, Arcosa has received valid consents sufficient to effect the applicable Proposed Amendments for both series of Arcosa Notes. Accordingly, Arcosa and the trustee under the Existing Arcosa Indentures have executed and delivered supplemental indentures relating to the applicable Proposed Amendments that will become operative upon the purchase by CRH AF of all Arcosa Notes validly tendered and not validly withdrawn into the applicable Tender Offer on the Early Settlement Date.

Each Offer will expire at 5:00 p.m., New York City time, on December 4, 2026, unless extended (such date and time, as the same may be extended, the “Expiration Date”) or earlier terminated. Holders who validly tender their Arcosa Notes into the applicable Offer after the Early Tender Deadline or Early Tender Date, as applicable, but on or prior to the Expiration Date, will not be eligible to receive the applicable early tender premium of $50 per $1,000 principal amount of Arcosa Notes accepted for purchase, with respect to the applicable Tender Offer, or $1,000 principal amount of New CRH AF Notes per $1,000 principal amount of Arcosa Notes accepted for exchange, with respect to the applicable Exchange Offer, and will instead receive the applicable tender consideration or exchange consideration as described in the Offer to Purchase or the Offering Memorandum, as applicable. CRH AF reserves the right, in its sole discretion, subject to applicable law, with respect to each Offer, (a) to accept for purchase and pay for all Arcosa Notes validly tendered on or before the Final Settlement Date and to keep the applicable Offer open or extend the Expiration Date to a later date and time as announced by CRH AF, (b) to waive any or all conditions to an Offer for Arcosa Notes tendered on or before the Expiration Date, (c) to extend, withdraw, terminate or amend the terms and conditions of such Offer, at any time and for any reason. Holders should not tender Arcosa Notes that they do not wish to be purchased or exchanged in the Offers.


LOGO

 

The New CRH AF Notes have not been registered with the Securities and Exchange Commission (the “SEC”) under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or with any securities regulatory authority of any State or other jurisdiction. The New CRH AF Notes may not be offered or sold in the United States or to, or for the account or benefit of, any U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

The Exchange Offers will only be made, and the New CRH AF Notes are only being offered and will only be issued, to holders of Arcosa Notes that are Eligible Holders (as defined in the Offering Memorandum).

TD Securities (USA) LLC is the sole Dealer Manager and Solicitation Agent for each of the Offers. Global Bondholder Services Corporation is the Tender Agent, Exchange Agent and Information Agent. Persons with questions regarding an Offer should contact TD Securities (USA) LLC (toll-free) at (866) 584-2096. Requests for copies of the Offer to Purchase, the Offering Memorandum and related materials should be directed to Global Bondholder Services Corporation at (212) 430-3774, (toll-free) (855) 654-2015 or contact@gbsc-usa.com. Questions regarding the tendering of Arcosa Notes may be directed to Global Bondholder Services Corporation (toll-free) at (855) 654-2015.

This press release is for informational purposes only. The Tender Offers, Exchange Offers and the Consent Solicitations are being made only to persons to whom such offers may be lawfully made and only pursuant to the Offer to Purchase or the Offering Memorandum, as applicable, and the information in this press release is qualified by reference to the Offer to Purchase or the Offering Memorandum, as applicable. This press release does not constitute an offer to sell or purchase, or the solicitation of an offer to sell or purchase, any securities including the Arcosa Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. No recommendation is made as to whether holders should tender any Arcosa Notes in response to the Tender Offers and, if they are Eligible Holders, the Exchange Offers. Holders must make their own decision as to whether to participate in the Tender Offers and, if they are Eligible Holders, the Exchange Offers and, if so, the principal amount of Arcosa Notes to tender.

****

Contacts

 

Danilo Juvane    Lauren Schulz
Head of Investor Relations    Chief Communications Officer
Danilo.Juvane@crh.com    Lauren.Schulz@crh.com

About CRH

CRH is the leading provider of building materials critical to modernizing infrastructure. With our team of 83,000 people across 4,000 locations, our unmatched scale, connected portfolio, and deep local relationships make us the partner of choice for transportation, water, and reindustrialization projects, shaping communities for a better tomorrow. CRH (NYSE: CRH) is a member of the S&P 500 Index. For more information, visit www.crh.com.


LOGO

 

Forward-Looking Statements

This press release contains statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may generally, but not always, be identified by the use of words such as “will,” “anticipates,” “should,” “could,” “would,” “targets,” “aims,” “may,” “continues,” “expects,” “is expected to,” “estimates,” “believes,” “intends” or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this press release.

In particular, the following, among other statements, are all forward-looking in nature: potential effect of the Proposed Amendments; expected timing of expiration of the Offers; expected Early Settlement Date; and anticipated maturity, interest rate, payment dates, and registration rights of the New CRH AF Notes.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future and reflect CRH’s current expectations and assumptions as to such future events and circumstances that may not prove accurate. You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this press release. CRH expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.

A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, certain of which are beyond our control, and which include, but are not limited to: economic and financial conditions, including changes in interest rates, inflation, price volatility and/or labor and materials shortages; the indebtedness incurred to finance CRH’s acquisition of Arcosa and its effect on CRH’s financial condition; and the risks and uncertainties described under “Risk Factors” in Part I, Item 1A in CRH’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 as filed with the SEC and in CRH’s other filings with the SEC.

Filing Exhibits & Attachments

5 documents

Keep reading